American Society of Hematology

SHERPA: Blue

People

  1. O'Reilly
    O'Reilly
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Papadopoulos
    Papadopoulos
  5. Perales
    Perales
  6. Castro-Malaspina
    Castro-Malaspina
  7. Jakubowski
    Jakubowski
  8. Landau
    Landau
  9. Kernan
    Kernan
  10. Ponce
    Ponce

Groups

  1. Department of Medicine (73)
  2. Hematologic Malignancies, Division of (73)
  3. Center for Hematologic Malignancies (59)
  4. Bone Marrow Transplant (51)
  5. GSK Faculty (48)
  6. Sloan Kettering Institute Faculty (47)
  7. Survivorship Research (47)
  8. Immunology Program Faculty (46)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (44)
  10. Pediatrics, Department of (44)
Search Within
  1. "Guenther Koehne"
Formats
  1. Meeting Abstract (62)
  2. Journal Article (11)
Groups
  1. Department of Medicine (73)
  2. Hematologic Malignancies, Division of (73)
  3. Center for Hematologic Malignancies (59)
  4. Bone Marrow Transplant (51)
  5. GSK Faculty (48)
  6. Sloan Kettering Institute Faculty (47)

More Groups

People
  1. Guenther Koehne (73)
  2. Richard O'Reilly (42)
  3. Sergio Giralt (41)
  4. Sean Devlin (27)
  5. Esperanza Papadopoulos (26)
  6. Miguel-Angel Perales (26)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2017 (6)
  4. 2016 (7)
  5. 2015 (7)
  6. 2014 (5)

More Years

Publications
  1. Blood (72)
  2. Blood Advances (1)

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
    Journal Article

    Lahoud, O. B.; Devlin, S. M.; Maloy, M. A.; Roeker, L. E.; Dahi, P. B.; Ponce, D. M.; Gyurkocza, B.; Koehne, G.; Young, J. W.; Castro-Malaspina, H. R.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma
    Meeting Abstract

    Bachier Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H. J.; Giralt, S.
    Blood (2018)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for multiple myeloma benefits patients with persistent disease and results in a high rate of residual disease clearance
    Meeting Abstract

    Getta, B.; Roshal, M.; Koehne, G.
    Blood (2017)

    Fulltext@MSK | Save
  • Targeting WT1 in hematologic malignancies?
    Journal Article

    Koehne, G.
    Blood (2017)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save